BeOne Medicines (ONC) Assets (2015 - 2026)
BeOne Medicines (ONC) reported Assets of $8.6 billion for Q1 2026, up 46.43% year-over-year from $5.8 billion in Q1 2025, and up 4.46% on a QoQ basis from $8.2 billion in Q4 2025.
BeOne Medicines (ONC) has 12 years of Assets data on file, last reported at $8.6 billion in Q1 2026.
- Quarterly Assets rose 46.43% year-over-year to $8.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 billion (up 46.43% YoY) and the FY2025 annual result came in at $8.2 billion, up 38.3% from the prior year.
- Assets grew to $8.6 billion in Q1 2026 per ONC's latest filing, from $8.2 billion in the prior quarter.
- Across five years, Assets topped out at $8.6 billion in Q1 2026 and bottomed at $5.5 billion in Q4 2022.
- The 5-year median for Assets is $5.9 billion (2024), against an average of $6.5 billion.
- The widest annual swing landed in 2022, when Assets plunged 35.78%; it then surged 46.43% in 2026.
- Tracing ONC's Assets over 5 years: stood at $5.5 billion in 2022, then advanced by 5.91% to $5.8 billion in 2023, then climbed by 1.99% to $5.9 billion in 2024, then soared by 38.3% to $8.2 billion in 2025, then climbed by 4.46% to $8.6 billion in 2026.
- Per Business Quant, the three latest ONC Assets figures stand at $8.6 billion (Q1 2026), $8.2 billion (Q4 2025), and $7.6 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 40.87 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 23.64 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 5.13 Bn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 8.55 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.55 Bn |
| Dec 31, 2025 | 8.19 Bn |
| Sep 30, 2025 | 7.63 Bn |
| Jun 30, 2025 | 6.30 Bn |
| Mar 31, 2025 | 5.84 Bn |
| Dec 31, 2024 | 5.92 Bn |
| Sep 30, 2024 | 5.83 Bn |
| Jun 30, 2024 | 5.71 Bn |
| Mar 31, 2024 | 5.67 Bn |
| Dec 31, 2023 | 5.81 Bn |
| Sep 30, 2023 | 5.52 Bn |
| Jun 30, 2023 | 5.73 Bn |
| Mar 31, 2023 | 5.96 Bn |
| Dec 31, 2022 | 5.48 Bn |
| Sep 30, 2022 | 6.73 Bn |
| Jun 30, 2022 | 7.38 Bn |
| Mar 31, 2022 | 8.02 Bn |
| Dec 31, 2021 | 8.54 Bn |
| Sep 30, 2021 | 5.29 Bn |
| Jun 30, 2021 | 5.52 Bn |
| Mar 31, 2021 | 5.82 Bn |
| Dec 31, 2020 | 5.60 Bn |
| Sep 30, 2020 | 5.57 Bn |
| Jun 30, 2020 | 3.90 Bn |
| Mar 31, 2020 | 4.07 Bn |
| Dec 31, 2019 | 1.61 Bn |
| Sep 30, 2019 | 1.88 Bn |
| Jun 30, 2019 | 2.15 Bn |
| Mar 31, 2019 | 2.17 Bn |
| Dec 31, 2018 | 2.25 Bn |
| Sep 30, 2018 | 2.41 Bn |
| Jun 30, 2018 | 1.65 Bn |
| Mar 31, 2018 | 1.71 Bn |
| Dec 31, 2017 | 1.05 Bn |
| Sep 30, 2017 | 1.05 Bn |
| Jun 30, 2017 | 473.98 Mn |
| Mar 31, 2017 | 376.73 Mn |
| Dec 31, 2016 | 405.81 Mn |
| Sep 30, 2016 | 235.43 Mn |
| Jun 30, 2016 | 251.23 Mn |
| Mar 31, 2016 | 265.23 Mn |
| Dec 31, 2015 | 116.76 Mn |